Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

BACKGROUND: Apixaban is a non-vitamin K antagonist oral anticoagulant (NOACs) recently emerged as an effective alternative to conventional vitamin K antagonists (VKAs) in the treatment of several thromboembolic disorders. However, in case of overdose or in patients requiring emergency surgery there...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmastri, Vittorio, Angelini, Andrea, Minerva, Vera, Ballarini, Melissa, Grammatico, Francesco, Todeschini, Paola, Pizzini, Attilia Maria, Silingardi, Mauro, La Manna, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327312/
https://www.ncbi.nlm.nih.gov/pubmed/37415195
http://dx.doi.org/10.1186/s13256-023-03949-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327312/
https://www.ncbi.nlm.nih.gov/pubmed/37415195
http://dx.doi.org/10.1186/s13256-023-03949-3

Ejemplares similares